Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 6/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.43 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.43 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.43 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.42 |
| ▸ | GRIK3 | Q13003 | 3/20 | 0.42 |
| ▸ | GRIK5 | Q16478 | 3/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.39 |
| ▸ | GGT1 | P19440 | 4/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.38 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.37 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL307010 | 0.83 | — | — | |
| SCHEMBL9701317 | 0.83 | GRIK1 (0.45) | GRIK1GRIK2GRM1GRM2GRIA4 | |
| Serine SCHEMBL1064689 | 0.83 | SLC1A1 (0.43) | GRIK1GRIK2GRM1GRM2GRIA4 | |
| SCHEMBL17222477 | 0.83 | GRIK1 (0.45) | GRIK1GRIK2GRM1GRM2GRIA4 | |
| SCHEMBL27399004 | 0.82 | GRIK1 (0.46) | GRIK1GRIK2GRM1GRM2GRIA4 | |
| SCHEMBL28048940 | 0.82 | GRIK1 (0.46) | GRIK1GRIK2GRM1GRM2GRIA4 | |
| Asparagine SCHEMBL7563049 | 0.81 | SLC1A1 (0.40) | GRIK1GRIK2GRM1GRM2GRIA4 | |
| SCHEMBL27578538 | 0.81 | — | — | |
| SCHEMBL27815508 | 0.80 | GSR (0.47) | GRIK1GRIK2GRM1GRM2GRIA4 | |
| SCHEMBL28204942 | 0.80 | GRIK1 (0.45) | GRIK1GRIK2GRM1GRM2GRIA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384221-A1 | CONTROLLED DRUG RELEASE MATERIAL | Aduro Material Ab (SE) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023018366-A1 | CONTROLLED DRUG RELEASE MATERIAL | ADURO MATERIAL AB (SE) | 2023-02-16 | — | — | WO | disclosed |
| EP-3102611-A1 | HUMANIZED BETA-AMYLOID BINDING MOLECULES AND USES THEREOF | Cangene Corporation (CA) | 2016-12-14 | — | — | EP | disclosed |
| WO-2015113169-A1 | HUMANIZED BETA-AMYLOID BINDING MOLECULES AND USES THEREOF | CNJ HOLDINGS, INC. (CA) | 2015-08-06 | — | — | WO | disclosed |
| CN-103966248-A | Bacterium gene point mutation molecular cloning technology based on homologus recombination | HANGZHOPU CT FOR DISEASE CONTROL AND PREVENTION | 2014-08-06 | — | — | CN | disclosed |
| CN-101365807-A | Polymerases for incorporation of nucleotide analogs | PACIFIC BIOSCIENCES CALIFORNIA (US) | 2009-02-11 | — | — | CN | disclosed |
| US-6303357-B1 | HEAT STABLE ENZYMATIC POLYPEPTIDE; FOR USE AS A DIAGNOSTIC TOOL IN MEASUREMENT OF LIPASE ACTIVITY AND DETERMINATION OF TRIGLYCERIDE, GLYCEROL, ADENOSINE TRIPHOSPHATE CONCENTRATIONS | AMANO PHARMACEUTICAL CO., LTD. (JP) | 2001-10-16 | — | — | US | disclosed |
| EP-1138769-A1 | Recombinant L-alpha-glycerophosphate oxidase gene, and method for producing the same | AMANO PHARMACEUTICAL CO., LTD. (JP) | 2001-10-04 | — | — | EP | disclosed |
| CN-1069346-C | Expression and secretion of hereologous proteins by yarrowia lipolytica transformants | PFIZER (US) | 2001-08-08 | — | — | CN | disclosed |
| CN-1034428-C | Expression and Secretion of Heterologous Proteins Using Yarrowia lipolytica Transformants | PFIZER (US) | 1997-04-02 | — | — | CN | disclosed |
| CN-1141339-A | Expression and secretion of hereologous proteins by yarrowia lipolytica transformants | PFIZER (US) | 1997-01-29 | — | — | CN | disclosed |
| CN-1138632-A | Expression and secretion of hereologous proteins by yarrowia lipolytica transformants | PFIZER (US) | 1996-12-25 | — | — | CN | disclosed |
| EP-0400010-A1 | SOLUBLE HUMAN CD4 FRAGMENTS AND USES THEREFOR | DANA-FARBER CANCER INSTITUTE (US) | 1990-12-05 | — | — | EP | disclosed |
| US-4921940-A | Process for the purification of Ti containing polycarbonate with solvent, complexing agent and water | XEROX CORPORATION (US) | 1990-05-01 | — | — | US | disclosed |
| WO-1989003222-A1 | SOLUBLE HUMAN CD4 FRAGMENTS AND USES THEREFOR | DANA-FABER CANCER INSTITUTE (US) | 1989-04-20 | — | — | WO | disclosed |